Company Registration No. 15274893 (England and Wales)
Ab Biotech Consulting Limited
Unaudited accounts
for the year ended 30 November 2025
Ab Biotech Consulting Limited
Unaudited accounts
Contents
Ab Biotech Consulting Limited
Company Information
for the year ended 30 November 2025
Director
Ashley Kim Browne
Company Number
15274893 (England and Wales)
Registered Office
222 Amesbury Avenue
Flat A
London
SW2 3BL
United Kingdom
Accountants
One Abacus Limited
Coldharbour Works
245a Coldharbour Lane
London
SW9 8RR
Ab Biotech Consulting Limited
Statement of financial position
as at 30 November 2025
Cash at bank and in hand
505
40,640
Creditors: amounts falling due within one year
(1,115)
(43,119)
Net current (liabilities)/assets
(610)
1
Called up share capital
1
1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 November 2025 and were signed on its behalf by
Ashley Kim Browne
Director
Company Registration No. 15274893
Ab Biotech Consulting Limited
Notes to the Accounts
for the year ended 30 November 2025
Ab Biotech Consulting Limited is a private company, limited by shares, registered in England and Wales, registration number 15274893. The registered office is 222 Amesbury Avenue, Flat A, London, SW2 3BL, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
3 years straight line basis
4
Tangible fixed assets
Computer equipment
Amounts falling due within one year
Ab Biotech Consulting Limited
Notes to the Accounts
for the year ended 30 November 2025
6
Creditors: amounts falling due within one year
2025
2024
Loans from directors
1,115
2,046
7
Average number of employees
During the year the average number of employees was 0 (2024: 0).